Table 4 Correlation between PCDHGA9 expression and clinical information of patients (n = 63)
From: The miR-1269a/PCDHGA9/CXCR4/β-catenin pathway promotes colorectal cancer invasion and metastasis
Group | Low expression of PCDHGA9 (42) | High expression of PCDHGA9 (21) | χ2 | P-value | |
|---|---|---|---|---|---|
Age (years) | < 65 (31) | 20 | 11 | 0.127 | 0.722 |
≥ 65 (32) | 22 | 10 | |||
Gender | Male (35) | 22 | 13 | 0.514 | 0.473 |
Female (28) | 20 | 8 | |||
Tumor location | Right hemicolon (25) | 16 | 9 | 0.133 | 0.716 |
Left hemicolon and retum (38) | 26 | 12 | |||
Tumor size | < 5 cm (53) | 25 | 10 | 0.804 | 0.370 |
≥ 5 cm (28) | 17 | 11 | |||
Stage of TNM | I + II (29) | 15 | 14 | 5.399 | 0.020* |
III + IV (34) | 27 | 7 | |||
Differentiation | Low and moderate (50) | 38 | 12 | 9.498 | 0.020* |
High (13) | 4 | 9 | |||
Invasion | To mucosa and submucosa layer (18) | 6 | 12 | 12.60 | 0.001** |
To muscle and serous layer (45) | 36 | 9 | |||
Lymphatic vascular metastasis | No (44) | 25 | 19 | 6.368 | 0.012* |
Yes (19) | 17 | 2 |